| MeSH term | MeSH ID | Detail |
|---|---|---|
| Hemolysis | D006461 | 131 associated lipids |
| Adenocarcinoma | D000230 | 166 associated lipids |
| Lung Neoplasms | D008175 | 171 associated lipids |
| Pancreatic Neoplasms | D010190 | 77 associated lipids |
| Colitis | D003092 | 69 associated lipids |
| Colonic Neoplasms | D003110 | 161 associated lipids |
| Cell Transformation, Neoplastic | D002471 | 126 associated lipids |
| Carcinoma, Hepatocellular | D006528 | 140 associated lipids |
| Seizures | D012640 | 87 associated lipids |
| Carcinoma, Non-Small-Cell Lung | D002289 | 72 associated lipids |
Oroxylin A
Oroxylin A is a lipid of Polyketides (PK) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 747 references associated with Oroxylin A in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for Oroxylin A
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Oroxylin A
NCBI Entrez Crosslinks
All references with Oroxylin A
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Zhang Q et al. | Determination of oroxylin A and oroxylin A 7-O-d-glucuronide in HepG2 cell lysate and subcellular fractions with SPE-UPLC-MS/MS: Cellular pharmacokinetic study to indicate anti-cancer mechanisms. | 2018 | J Pharm Biomed Anal | pmid:29571134 |
| Chen W et al. | Activation of autophagy is required for Oroxylin A to alleviate carbon tetrachloride-induced liver fibrosis and hepatic stellate cell activation. | 2018 | Int. Immunopharmacol. | pmid:29414645 |
| Jin H et al. | Oroxylin A inhibits ethanol-induced hepatocyte senescence via YAP pathway. | 2018 | Cell Prolif. | pmid:29318697 |
| Jin J et al. | Oroxylin A suppresses influenza A virus replication correlating with neuraminidase inhibition and induction of IFNs. | 2018 | Biomed. Pharmacother. | pmid:29091888 |
| Wu SC et al. | Baicalin protects mice against Salmonella typhimurium infection via the modulation of both bacterial virulence and host response. | 2018 | Phytomedicine | pmid:30195877 |
| Zhang C et al. | Oroxylin A prevents angiogenesis of LSECs in liver fibrosis via inhibition of YAP/HIF-1α signaling. | 2018 | J. Cell. Biochem. | pmid:28857294 |
| Shimizu T et al. | Synergistic effect of baicalein, wogonin and oroxylin A mixture: multistep inhibition of the NF-κB signalling pathway contributes to an anti-inflammatory effect of Scutellaria root flavonoids. | 2018 | J Nat Med | pmid:28921127 |
| Jin H et al. | Oroxylin A prevents alcohol-induced hepatic steatosis through inhibition of hypoxia inducible factor 1alpha. | 2018 | Chem. Biol. Interact. | pmid:29476730 |
| Chassagne F et al. | A metabolomic approach to identify anti-hepatocarcinogenic compounds from plants used traditionally in the treatment of liver diseases. | 2018 | Fitoterapia | pmid:29477305 |
| Mangal P et al. | Screening of six Ayurvedic medicinal plants for anti-obesity potential: An investigation on bioactive constituents from Oroxylum indicum (L.) Kurz bark. | 2017 | J Ethnopharmacol | pmid:27469197 |
| Chen M et al. | Simultaneous determination of wogonin, oroxylin a, schisandrin, paeoniflorin and emodin in rat serum by HPLC-MS/MS and application to pharmacokinetic studies. | 2017 | Biomed. Chromatogr. | pmid:28236316 |
| Han Q et al. | Oroxylin A inhibits HO-induced oxidative stress in PC12 cells. | 2017 | Nat. Prod. Res. | pmid:27820974 |
| Tan C et al. | Oroxylin a could be a Promising Radiosensitizer for Esophageal Squamous Cell Carcinoma by Inducing G2/M Arrest and Activating Apoptosis. | 2017 | Pathol. Oncol. Res. | pmid:27585443 |
| Li W et al. | Oroxylin A reverses the drug resistance of chronic myelogenous leukemia cells to imatinib through CXCL12/CXCR7 axis in bone marrow microenvironment. | 2017 | Mol. Carcinog. | pmid:27533597 |
| Wei L et al. | Oroxylin A activates PKM1/HNF4 alpha to induce hepatoma differentiation and block cancer progression. | 2017 | Cell Death Dis | pmid:28726775 |
| Ni T et al. | Oroxylin A suppresses the development and growth of colorectal cancer through reprogram of HIF1α-modulated fatty acid metabolism. | 2017 | Cell Death Dis | pmid:28594405 |
| Shen L et al. | Oroxylin A inhibits the generation of Tregs in non-small cell lung cancer. | 2017 | Oncotarget | pmid:28472762 |
| Fu X et al. | A general strategy for the synthesis of homogeneous hyaluronan conjugates and their biological applications. | 2017 | Chem. Commun. (Camb.) | pmid:28286894 |
| Yu H et al. | Enhancement of solubility and dissolution rate of baicalein, wogonin and oroxylin A extracted from Radix scutellariae. | 2017 | Int J Pharm | pmid:28642200 |
| Liu RX et al. | Distribution patterns of the contents of five biologically activate ingredients in the root of Scutellaria baicalensis. | 2017 | Chin J Nat Med | pmid:28284428 |